Literature DB >> 7272132

Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease?

M Tièche, G A Lupi, F Gutzwiller, P J Grob, H Studer, H Bürgi.   

Abstract

Assessments were made of 945 consecutive hospital patients with regard to a relation between borderline low thyroid function (recognised by a slightly raised thyroid stimulating hormone), thyroid autoimmunity, serum cholesterol, and coronary heart disease. Men and women with a thyroid autoimmunity, serum cholesterol, and coronary heart disease. Men and women with a thyroid stimulating hormone of 4.0 mU/l or over had a higher prevalence of coronary heart disease than did age-matched controls, and this difference was significant in women. The excess of coronary heart disease was not explained by an excess of other risk factors such as a high cholesterol, hypertension, smoking, and diabetes. Women with thyroid antibodies had a slightly higher prevalence of coronary heart disease despite the unexpected finding of a lower serum cholesterol. The data point to an association between borderline thyroid function and autoimmunity and coronary heart disease which is not mediated through a raised serum cholesterol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272132      PMCID: PMC482629          DOI: 10.1136/hrt.46.2.202

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  The significance of the association of tissue autoantibodies and rheumatoid factor with angina in the Busselton population.

Authors:  J D Mathews; B M Rodger; N S Stenhouse
Journal:  J Chronic Dis       Date:  1976-06

2.  Diagnostic index for premyxoedema.

Authors:  H Ikram; S Banim; P B Fowler
Journal:  Lancet       Date:  1973-12-22       Impact factor: 79.321

3.  Serum-thyrotrophin in symptomless autoimmune thyroiditis.

Authors:  A Gordin; O P Heinonen; P Saarinen; B A Lamberg
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

4.  Symptomless autoimmune thyroiditis in coronary heart-disease.

Authors:  O P Heinonen; A Gordin; K Aho; S Punsar; K Pyörälä; K Puro
Journal:  Lancet       Date:  1972-04-08       Impact factor: 79.321

5.  Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

Authors:  L A Carlson; L E Böttiger
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

6.  Preclinical hypothyroidism: a risk factor for coronary heart-disease.

Authors:  P A Bastenie; L Vanhaelst; M Bonnyns; P Neve; M Staquet
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

7.  Serum thyrotrophin in myxedema and in asymptomatic atrophic thyroiditis.

Authors:  M Bonnyns; P A Bastenie
Journal:  J Clin Endocrinol Metab       Date:  1967-06       Impact factor: 5.958

8.  Grades of hypothyroidism.

Authors:  D C Evered; B J Ormston; P A Smith; R Hall; T Bird
Journal:  Br Med J       Date:  1973-03-17

9.  Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism.

Authors:  A D Santos; R P Miller; P K Mathew; W A Wallace; W T Cave; L Hinojosa
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

10.  Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies.

Authors:  P A Bastenie; L Vanhaelst; J Golstein; P Smets
Journal:  Lancet       Date:  1977-07-23       Impact factor: 79.321

View more
  17 in total

1.  Coronary flow reserve is impaired in subclinical hypothyroidism.

Authors:  Semra Baycan; Dogan Erdogan; Mustafa Caliskan; Baris Onder Pamuk; Ozgur Ciftci; Hakan Gullu; Aylin Yildirir; Nilgun D Guvener; Haldun Muderrisoglu
Journal:  Clin Cardiol       Date:  2007-11       Impact factor: 2.882

2.  Hyperthyrotrophinaemia during thyroxine replacement therapy.

Authors:  P McClelland; A Stott; W Howel-Evans
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

3.  Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus.

Authors:  G Radetti; C Paganini; L Gentili; S Bernasconi; C Betterle; M Borkenstein; K Cvijovic; M Kadrnka-Lovrencic; C Krzisnik; T Battelino
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

4.  The effects of experimental hypothyroidism on hemorheology and plasma fibrinogen concentration.

Authors:  Selmin Toplan; Nuran Dariyerli; Semra Ozdemir; Mehmet Can Akyolcu; Hüsrev Hatemi; Günnur Yigit
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

5.  Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.

Authors:  P De Whalley
Journal:  Br J Gen Pract       Date:  1995-02       Impact factor: 5.386

Review 6.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

7.  Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.

Authors:  J V Parle; J A Franklyn; K W Cross; S R Jones; M C Sheppard
Journal:  Br J Gen Pract       Date:  1993-03       Impact factor: 5.386

8.  Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism?

Authors:  D Pallas; D A Koutras; P Adamopoulos; P Marafelia; A Souvatzoglou; G Piperingos; S D Moulopoulos
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

9.  Thyroid function is associated with presence and severity of coronary atherosclerosis.

Authors:  J Auer; R Berent; T Weber; E Lassnig; B Eber
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

Review 10.  Subclinical thyroid disease.

Authors:  J W Elte; A H Mudde; A C Nieuwenhuijzen Kruseman
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.